Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ
OPALKA, B, WANDL, U. B, BECHER, R, KLOBE, O, NAGEL-HIEMKE, M, MORITZ, T, BEER, U, SEEBER, S, NIEDERLE, N
Published in Blood (01.11.1991)
Get full text
Published in Blood (01.11.1991)
Journal Article
Epirubicin and ifosfamide in metastatic breast cancer
Becher, R, Kloke, O, Hayungs, J, Hartwich, G, Bartels, H, Szanto, J, Wolf, E, Illiger, H J, Halabi, S, Rieche, K, Hering, K G, Ohl, S, DeDycker, R, Huhn, R, Fischedick, A R, Höfeler, H, Pielken, H J, Hawig, I, Hirche, H, Seeber, S
Published in Seminars in oncology (01.06.1996)
Get more information
Published in Seminars in oncology (01.06.1996)
Journal Article